Morten Grunnet is the founder of Acesion Pharma. Acesion Pharma has raised $51M in total funding. Latest round: Series B. Based in Copenhagen, Denmark.
Morten Grunnet is the Co-founder and founding CEO of Acesion Pharma, a Danish biopharmaceutical company focused on developing novel therapies for atrial fibrillation. He led the company from 2011 to 2016, overseeing its establishment and securing seed and Series A funding.
Full founder directory · Investor directory · Company funding database · Fundraising library